UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical infectious diseases, ISSN 1058-4838, 4/2010, Volume 50, Issue 8, pp. 1101 - 1111
Aspergillus | Invasive candidiasis | Surveillance | Lungs | Aspergillosis | Cryptococcosis | Transplantation | Infections | Fungal infections | ARTICLES AND COMMENTARIES | Mold | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Mycoses - epidemiology | United States - epidemiology | Prospective Studies | Humans | Middle Aged | Transplants - adverse effects | Child, Preschool | Infant | Male | Incidence | Young Adult | Adolescent | Aged, 80 and over | Adult | Female | Aged | Immunocompromised Host | Child | Sentinel Surveillance | Cohort Studies | Demographic aspects | Distribution | Mycoses | Organ transplant recipients | Reports | Forecasts and trends | Research | Sentinel health events | Transplants & implants | Blood & organ donations | Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 06/2010, Volume 149, Issue 5, pp. 675 - 692
EBV | diagnostic haematology | lymphoproliferative disease | Transplant | Lymphoproliferative disease | Diagnostic haematology | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Infectious diseases | Medical sciences | Viral diseases | Lymphoproliferative Disorders - diagnosis | Humans | Organ Transplantation - adverse effects | Risk Factors | Epstein-Barr Virus Infections - complications | Postoperative Care - methods | Lymphoproliferative Disorders - pathology | Lymphoproliferative Disorders - etiology | Population Surveillance - methods | Preoperative Care - methods | Transplantation of organs, tissues, etc | Organ transplant recipients | Immunotherapy | Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 06/2010, Volume 149, Issue 5, pp. 693 - 705
transplant | lymphoproliferative | chemotherapy | therapy | Therapy | Chemotherapy | Lymphoproliferative | Transplant | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Evidence-Based Medicine - methods | Reoperation | Immunotherapy, Adoptive - methods | Antibodies, Monoclonal, Murine-Derived | Prognosis | Drug Administration Schedule | Humans | Rituximab | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Lymphoproliferative Disorders - therapy | Algorithms | Organ Transplantation - adverse effects | Adult | Immunosuppressive Agents - adverse effects | Immunosuppressive Agents - administration & dosage | Lymphoproliferative Disorders - etiology | Transplantation of organs, tissues, etc | Organ transplant recipients | Immunotherapy | Cancer | Index Medicus
Journal Article
American journal of transplantation, ISSN 1600-6135, 11/2008, Volume 8, Issue 11, pp. 2192 - 2198
mTOR inhibitors | Immunosuppression | skin cancer treatment | organ transplantation | skin cancer prophylaxis | sun‐screen | Sun-screen | Skin cancer treatment | Skin cancer prophylaxis | Organ transplantation | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Fundamental and applied biological sciences. Psychology | Fundamental immunology | Tumors of the skin and soft tissue. Premalignant lesions | Tissue, organ and graft immunology | Dermatology | Biological and medical sciences | Medical sciences | Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases | Medical Oncology - methods | Dermatology - methods | Humans | Risk | Treatment Outcome | Clinical Trials as Topic | Incidence | Carcinoma, Squamous Cell - etiology | Keratosis - therapy | Organ Transplantation - adverse effects | Carcinoma, Basal Cell - etiology | Immunosuppressive Agents - adverse effects | Skin Neoplasms - etiology | Transplantation of organs, tissues, etc | Skin cancer | Index Medicus
Journal Article
American journal of transplantation, ISSN 1600-6135, 03/2008, Volume 8, Issue 3, pp. 667 - 672
obesity | outcomes research | Liver transplantation | Outcomes research | Obesity | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Liver, biliary tract, pancreas, portal circulation, spleen | Biological and medical sciences | Metabolic diseases | Medical sciences | Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases | Surgery of the digestive system | Body Mass Index | United States - epidemiology | Body Weight | National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | Obesity - complications | Humans | Middle Aged | Graft Survival | Liver Transplantation - mortality | Male | Survival Rate | Treatment Outcome | Ascites - diagnosis | Contraindications | Female | Ascites - pathology | Databases, Factual | Evaluation | Databases | Kidney diseases | Liver | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 5/2009, Volume 48, Issue 9, pp. 1276 - 1284
Tuberculosis | Mycobacterium tuberculosis | Liver | Antituberculars | Pulmonary tuberculosis | Latent tuberculosis | Immunocompromised Hosts | Infections | Transplantation | Renal tuberculosis | Tuberculin | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Bacterial diseases | Human bacterial diseases | Tuberculosis and atypical mycobacterial infections | Tuberculosis - epidemiology | Tuberculosis - mortality | Humans | Immunosuppressive Agents - therapeutic use | Spain | Drug Interactions | Organ Transplantation - adverse effects | Tuberculosis - drug therapy | Antitubercular Agents - administration & dosage | Immunosuppressive Agents - adverse effects | Rifampin - therapeutic use | Rifampin - administration & dosage | Antitubercular Agents - therapeutic use | Drugs | Care and treatment | Demographic aspects | Immunocompromised host | Patient outcomes | Organ transplant recipients | Physiological aspects | Health aspects | Risk factors | Index Medicus
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2007, Volume 67, Issue 8, pp. 1167 - 1198
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Neoplasms - virology | Neoplasms - etiology | Time Factors | Humans | Protein Kinases - physiology | Risk Factors | Immunosuppressive Agents - adverse effects | Neoplasms - prevention & control | Organ Transplantation | TOR Serine-Threonine Kinases | Immunosuppressive Agents - pharmacology | Neoplasms - epidemiology
Journal Article